Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression?

Journal of Neural Transmission

Volumn 121, Issue 8, 2014, Pages 925-932

  Dantzer, Robert ^a   Walker, Adam K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Depression; Glutamate; Inflammation; Kynureninie; Microglia; Tryptophan

Indexed keywords

GLUTAMIC ACID; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; QUINOLINIC ACID; TRYPTOPHAN;

BIOAVAILABILITY; BLOOD BRAIN BARRIER; CHRONIC INFLAMMATION; EFFUSION; EXCITOTOXICITY; HUMAN; INFLAMMATION INDUCED DEPRESSION; MAJOR DEPRESSION; MICROGLIA; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW; AMINO ACID BLOOD LEVEL; ARTICLE; DEPRESSION; DISEASE ASSOCIATION; ENZYME ACTIVATION; IMMUNE SYSTEM; INFLAMMATION; ANIMAL; COMPLICATION; DEPRESSIVE DISORDER; IMMUNOMODULATION; METABOLISM;

ANIMALS; BLOOD-BRAIN BARRIER; DEPRESSIVE DISORDER; GLUTAMIC ACID; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INFLAMMATION; KYNURENINE; NEUROIMMUNOMODULATION; QUINOLINIC ACID;

EID: 84925702647     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-014-1187-1     Document Type: Review

References (65)

1. Andreetta F, Barnes NM, Wren PB, Carboni L (2013) p38 MAP kinase activation does not stimulate serotonin transport in rat brain: implications for sickness behaviour mechanisms. Life Sci 93:30-37. doi:10.1016/j.lfs.2013.05.014
2. Benton T, Staab J, Evans DL (2007) Medical co-morbidity in depressive disorders. Ann Clin Psychiatry Off J Am Acad Clin Psychiatr 19:289-303. doi:10.1080/10401230701653542 (Pubitemid 350208802)
3. Berman RM et al (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47:351-354 (Pubitemid 30109248)
4. Boado RJ, Li JY, Nagaya M, Zhang C, Pardridge WM (1999) Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proc Natl Acad Sci USA 96:12079-12084 (Pubitemid 29502861)
5. Campos F et al (2011) Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: an experimental study. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 31:1378-1386. doi:10.1038/jcbfm.2011.3
6. Capuron L et al (2002a) Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol 26:643-652. doi:10.1016/S0893-133X(01)00407-9
7. Capuron L et al (2002b) Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry 7:468-473. doi:10.1038/sj.mp.4000995 (Pubitemid 34712898)
8. Cohen-Kashi-Malina K, Cooper I, Teichberg VI (2012) Mechanisms of glutamate efflux at the blood-brain barrier: involvement of glial cells. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 32:177-189. doi:10.1038/jcbfm.2011.121
9. Conrad M, Sato H (2012) The oxidative stress-inducible cystine/glutamate antiporter, system x(c) (-): cystine supplier and beyond. Amino Acids 42:231-246. doi:10.1007/s00726-011-0867-5
10. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46-56. doi:10.1038/nrn2297 (Pubitemid 350295688)
11. Denicoff KD et al (1987) The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann Intern Med 107:293-300 (Pubitemid 17136929)
12. Eastman CL, Guilarte TR (1989) Cytotoxicity of 3-hydroxykynurenine in a neuronal hybrid cell line. Brain Res 495:225-231 (Pubitemid 19213559)
13. Elovainio M et al (2011) Moderating effect of indoleamine 2,3-dioxygenase (IDO) activation in the association between depressive symptoms and carotid atherosclerosis: evidence from the Young Finns study. J Affect Disord 133:611-614. doi:10.1016/j.jad.2011.04.025
14. Erhardt S et al (2013) Connecting inflammation with glutamate agonism in suicidality. Neuropsychopharmacology 38:743-752. doi:10.1038/npp.2012.248
15. Eugenin EA et al (2001) Microglia at brain stab wounds express connexin 43 and in vitro form functional gap junctions after treatment with interferon-gamma and tumor necrosis factor-alpha. Proc Natl Acad Sci USA 98:4190-4195. doi:10.1073/pnas.051634298 (Pubitemid 32249920)
16. Evans DL et al (2005) Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 58:175-189. doi:10.1016/j.biopsych. 2005.05.001 (Pubitemid 41112265)
17. Fu X et al (2010) Central administration of lipopolysaccharide induces depressive-like behavior in vivo and activates brain indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures. J Neuroinflamm 7:43. doi:10.1186/1742-2094-7-43
18. Fukui S, Schwarcz R, Rapoport SI, Takada Y, Smith QR (1991) Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J Neurochem 56:2007-2017
19. Gabbay V, Ely BA, Babb J, Liebes L (2012) The possible role of the kynurenine pathway in anhedonia in adolescents. J Neural Transm 119:253-260. doi:10.1007/s00702-011-0685-7
20. Garcia LS et al (2008) Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Progr Neuropsychopharmacol Biol Psychiatry 32:140-144
21. Gold AB et al (2011) The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment. J Neuroinflamm 8:17. doi:10.1186/1742-2094-8-17
22. Goldberg D (2010) The detection and treatment of depression in the physically ill. World Psychiatry Off J World Psychiatr Assoc 9:16-20
23. Gras G et al (2012) EAAT expression by macrophages and microglia: still more questions than answers. Amino Acids 42:221-229. doi:10.1007/s00726-011- 0866-6
24. Helms HC, Madelung R, Waagepetersen HS, Nielsen CU, Brodin B (2012) In vitro evidence for the brain glutamate efflux hypothesis: brain endothelial cells cocultured with astrocytes display a polarized brain-to-blood transport of glutamate. Glia 60:882-893. doi:10.1002/glia.22321
25. Heyes MP, Quearry BJ, Markey SP (1989) Systemic endotoxin increases L-tryptophan, 5-hydroxyindoleacetic acid, 3-hydroxykynurenine and quinolinic acid content of mouse cerebral cortex. Brain Res 491:173-179 (Pubitemid 19159090)
26. Hosoya K, Sugawara M, Asaba H, Terasaki T (1999) Blood-brain barrier produces significant efflux of L-aspartic acid but not Daspartic acid: in vivo evidence using the brain efflux index method. J Neurochem 73:1206-1211 (Pubitemid 29395480)
27. Irwin MR, Miller AH (2007) Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun 21:374-383. doi:10.1016/j.bbi.2007. 01.010 (Pubitemid 46528684)
28. Kigerl KA et al (2012) System x(c)(-) regulates microglia and macrophage glutamate excitotoxicity in vivo. Exp Neurol 233:333-341. doi:10.1016/j. expneurol.2011.10.025
29. Kita T, Morrison PF, Heyes MP, Markey SP (2002) Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the L-kynurenine and quinolinic acid pools in brain. J Neurochem 82:258-268 (Pubitemid 34774617)
30. Kurz K, Schroecksnadel S, Weiss G, Fuchs D (2011) Association between increased tryptophan degradation and depression in cancer patients. Curr Opin Clin Nutr Metab Care 14:49-56. doi:10.1097/MCO.0b013e328340d849
31. Larkin GL, Beautrais A (2011) A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation. Int J Neuropsychopharmacol 14:1127-1131
32. Lawson MA et al (2013) Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2,3-dioxygenase-dependent depression-like behaviors. J Neuroinflamm 10:87. doi:10.1186/1742-2094-10-87
33. Leibowitz A, Boyko M, Shapira Y, Zlotnik A (2012) Blood glutamate scavenging: insight into neuroprotection. Int J Mol Sci 13:10041-10066. doi:10.3390/ijms130810041
34. Maeng S, Zarate CA Jr (2007) The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects. Curr Psychiatry Rep 9:467-474 (Pubitemid 350284937)
35. Mattox ML, D'Angelo JA, Grimes ZM, Fiebiger E, Dickinson BL (2012) The cystine/glutamate antiporter regulates indoleamine 2,3-dioxygenase protein levels and enzymatic activity in human dendritic cells. Am J Clin Exp Immunol 1:113-123
36. Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR (2008) Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol Off J Am Soc Clin Oncol 26:971-982. doi:10.1200/JCO.2007. 10.7805 (Pubitemid 351409339)
37. Moreau M et al (2008) Inoculation of Bacillus Calmette-Guerin to mice induces an acute episode of sickness behavior followed by chronic depressive-like behavior. Brain Behav Immun 22:1087-1095. doi:10.1016/j.bbi. 2008.04.001
38. Nagy D et al (2010) Effects of blood glutamate scavenging on cortical evoked potentials. Cell Mol Neurobiol 30:1101-1106. doi:10.1007/s10571-010-9542- 8
39. Nosyreva E et al (2013) Acute suppression of spontaneous neurotransmission drives synaptic potentiation. J Neurosci 33:6990-7002
40. O'Connor JC et al (2009a) Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J Neurosci Off J Soc Neurosci 29:4200-4209. doi:10.1523/JNEUROSCI.5032-08.2009
41. O'Connor JC et al (2009b) Induction of IDO by bacille Calmette-Guerin is responsible for development of murine depressive-like behavior. J Immunol 182:3202-3212. doi:10.4049/jimmunol.0802722
42. O'Connor JC et al (2009c) Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 14:511-522. doi:10.1038/sj.mp.4002148
43. Obrenovitch TP, Urenjak J (2003) Accumulation of quinolinic acid with neuroinflammation: does it mean excitotoxicity? Adv Exp Med Biol 527:147-154 (Pubitemid 38197639)
44. Omidi Y, Barar J, Ahmadian S, Heidari HR, Gumbleton M (2008) Characterization and astrocytic modulation of system L transporters in brain microvasculature endothelial cells. Cell Biochem Funct 26:381-391. doi:10.1002/cbf.1455 (Pubitemid 351613181)
45. Piani D, Spranger M, Frei K, Schaffner A, Fontana A (1992) Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur J Immunol 22:2429-2436. doi:10.1002/eji. 1830220936
46. Raison CL, Miller AH (2013) Do cytokines really sing the blues? Cerebrum Dana Forum Brain Sci 2013:10
47. Raison CL et al (2010) CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry 15:393-403. doi:10.1038/mp.2009.116
48. Raison CL et al (2013) A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. J Am Med Assoc Psychiatry 70:31-41. doi:10.1001/2013.jamapsychiatry.4
49. Renault PF et al (1987) Psychiatric complications of long-term interferon alfa therapy. Arch Intern Med 147:1577-1580 (Pubitemid 17138838)
50. Ruban A, Mohar B, Jona G, Teichberg VI (2013) Blood glutamate scavenging as a novel neuroprotective treatment for paraoxon intoxication. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab. doi:10.1038/jcbfm.2013.186
51. Saito K, Markey SP, Heyes MP (1992) Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse. Neuroscience 51:25-39
52. Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ (2012) Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci 13:465-477. doi:10.1038/nrn3257
53. Smith AJ, Smith RA, Stone TW (2009) 5-Hydroxyanthranilic acid, a tryptophan metabolite, generates oxidative stress and neuronal death via p38 activation in cultured cerebellar granule neurones. Neurotox Res 15:303-310. doi:10.1007/s12640-009-9034-0
54. Steiner J et al (2011) Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? J Neuroinflamm 8:94. doi:10.1186/1742-2094-8-94
55. Sublette ME, Postolache TT (2012) Neuroinflammation and depression: the role of indoleamine 2,3-dioxygenase (IDO) as a molecular pathway. Psychosom Med 74:668-672. doi:10.1097/PSY.0b013e318268de9f
56. Swardfager W et al (2009) Indoleamine 2,3-dioxygenase activation and depressive symptoms in patients with coronary artery disease. Psychoneuroendocrinology 34:1560-1566. doi:10.1016/j.psyneuen.2009.05.019
57. Takaki J et al (2012) L-Glutamate released from activated microglia downregulates astrocytic L-glutamate transporter expression in neuroinflammation: the 'collusion' hypothesis for increased extracellular L-glutamate concentration in neuroinflammation. J Neuroinflamm 9:275. doi:10.1186/1742-2094-9-275
58. Takeuchi H et al (2006) Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. J Biol Chem 281:21362-21368. doi:10.1074/jbc.M600504200 (Pubitemid 44115475)
59. Teichberg VI, Cohen-Kashi-Malina K, Cooper I, Zlotnik A (2009) Homeostasis of glutamate in brain fluids: an accelerated brain-to-blood efflux of excess glutamate is produced by blood glutamate scavenging and offers protection from neuropathologies. Neuroscience 158:301-308. doi:10.1016/j. neuroscience.2008.02.075
60. Tyring S et al (2006) Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 367:29-35. doi:10.1016/S0140-6736(05)67763-X (Pubitemid 43038667)
61. van Heesch F et al (2013) Lipopolysaccharide-induced anhedonia is abolished in male serotonin transporter knockout rats: an intracranial self-stimulation study. Brain Behav Immun 29:98-103. doi:10.1016/j.bbi.2012.12. 013
62. Widner B, Laich A, Sperner-Unterweger B, Ledochowski M, Fuchs D (2002) Neopterin production, tryptophan degradation, and mental depression - what is the link? Brain Behav Immun 16:590-595 (Pubitemid 35333739)
63. Walker AK et al (2013) NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice. Neuropsychopharmacology Off Publ Am Coll Neuropsychopharmacol 38:1609-1616. doi:10.1038/npp.2013.71
64. Yawata I et al (2008) Macrophage-induced neurotoxicity is mediated by glutamate and attenuated by glutaminase inhibitors and gap junction inhibitors. Life Sci 82:1111-1116. doi:10.1016/j.lfs.2008.03.010
65. Zhu CB et al (2010) Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol 35:2510-2520. doi:10.1038/npp.2010.116